GI & Endoscopy

The U.S. will be among the nations with the largest increases in Crohn's disease burden from 2016 to 2026, according to analytics company GlobalData.

Here are eight updates on GI companies from the past week:

Reston, Va.-based The Gastroenterology Group will begin offering clinical research to its patients through a partnership with Elligo Health Research.

Ammar Hemaidan, MD, is a gastroenterologist at Daytona Beach, Fla.-based Advanced Medical Center.

Copenhagen, Denmark-based Zealand Pharma and UniQuest, the commercialization company of The University of Queensland in Australia, are collaborating to develop new drug candidates inspired by venoms to treat gastrointestinal diseases.

William Chey, MD, is joining Ritter Pharmaceuticals' medical advisory board.

The Medical Board of California accused gastroenterologist Parminder Singh Dhaliwal, MD, of alleged gross negligence, OC Weekly reports.

Atul Vachhani, MD, is a gastroenterologist at Santa Maria (Calif.) Gastroenterology.

Mount Vernon, Ill.-based Crossroads Specialty Clinic added gastroenterologist Khalid Naseer, MD, to its staff, Southern Business Journal reports.

Enhanced recovery protocols improve clinical outcomes before, during and after colorectal operations, Science Business reports.